|
|
|
|
|
|
|
Coherus BioSciences- Inc. (CHRS)
|
|
19 0.25 (1.33%)
|
08-17 16:00
|
|
Open:
|
18.8
|
Pre. Close:
|
18.75
|
|
High:
|
19.1
|
Low:
|
18.5
|
|
Volume:
|
321,504
|
Market Cap:
|
1289M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
19.125 - 19.202
|
19.202 - 19.276
|
|
Low:
|
18.309 - 18.394
|
18.394 - 18.475
|
|
Close:
|
18.882 - 19.017
|
19.017 - 19.146
|
|
|
|
Technical analysis (as of: 2018-08-17 4:24:09 PM)
|
|
Overall:
|
 
|
|
Stoxline posted a NEUTRAL today, upgraded from lower rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.
|
|
Target:
|
Six months: 22.89 One year: 26.74
|
|
Support:
|
Support1: 16.39 Support2: 14.40
|
|
Resistance:
|
Resistance1:
19.60 Resistance2: 22.89
|
|
Pivot:
|
18.60
|
|
Moving Averages:
|
MA(5): 18.86 MA(20): 18.58
MA(100): 15.29 MA(250): 12.90
|
|
MACD:
|
MACD(12,26):
0.61  Signal(12,26,9): 0.67
|
|
%K %D:
|
%K(14,3): 62.94 %D(3): 66.33
|
|
RSI:
|
RSI(14): 59.09
|
|
52-Week:
|
High: 19.6
Low: 8.05 Change(%): 40.4
|
|
Average Vol(K):
|
3-Month: 64995
10-Days 32242
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.CHRS has closed below upper band by 23.5%. Bollinger Bands are 52.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to CHRS's normal range. The bands have been in this narrow range for 8 bars. This is a sign that the market may be about to initiate a new trend.
|
|
|
Headline News
|
|
2018-08-08T22:48:03-04:00
Coherus BioSciences' (CHRS) CEO Dennis Lanfear on Q2 2018 Results - Earnings Call Transcript
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
